Naga Chalasani, M.D., who is the lead author of this study and Professor of Gastroenterology and Hepatology and Interim Chair in the Department of Medicine at Indiana University in the USA, commented ...

Primary sclerosing cholangitis (PSC) is a chronic, progressive inflammatory disease characterized by fibrosis and bile duct ...

SAN FRANCISCO--(BUSINESS WIRE)--Perspectum announced recruitment of the first patient in a multi-center collaborative study to characterize Primary Sclerosing Cholangitis in children, “Prospective ...

Sayed “Obi” Aseem, M.D., Ph.D., is an assistant professor in the VCU School of Medicine’s Department of Internal Medicine and is part of the VCU Stravitz-Sanyal Institute for Liver Disease and ...

We apologize, but this video has failed to load. Try refreshing your browser, or tap here to see other videos from our team. PSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, ...

Primary Sclerosing Cholangitis (PSC) is a debilitating rare disease of the liver with no effective treatment. Reported in Nature Genetics researchers from the Wellcome Trust Sanger Institute, Mayo ...

Coffee and cigarette smoking may protect against the rare liver disease Primary Sclerosing Cholangitis (PSC), study shows. Coffee and cigarette smoking may protect against the rare liver disease ...

Table 1 Association summary statistics across four newly associated PSC risk loci Figure 1: Odds ratios (and their 95% confidence intervals) for PSC, UC and CD across the six PSC-associated SNPs ...

Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas. Thirty-four patients were treated with 53 cycles of PSC 833 and etoposide. Steady-state ...

Primary Sclerosing Cholangitis (PSC) is a debilitating rare disease of the liver with no effective treatment. Researchers have now identified four regions of the genome associated with the disease, ...